Additionally, although we found germline variants in certain genes in both patient datasets (eg. BRCA1, BRCA2, and MUTYH), some genes were exclusively mutated in either CS/CS-like/BRRS patients or in TCGA PHTS component cancers. This evidence concerns the gene BRCA2 and cancer.